Home   About this service   Get the news  
+32 2 743 34 03

 
UCB [BE0003739530 / UCB]

UCB Media Room - Transparency Notifications

INFORMATION REGLEMENTEE


[07/08/2019 | 20:01]
https://u7061146.ct.sendgrid.net/wf/click?upn=3DG62jSYfZdO-2F12d8lSllQBx1W2=
7HkUdGSImvHQ6HnxeeiysVZrCZyCvoCjypIVyRozhYtKRQKYQL7a7-2BEWqaq3VuUWUfPDeyZS3=
Kqd9-2BHkdKNsyFbAUPXmpSaKHQeW83-2F_-2B-2Ft0TnE1oEbVIWS8vHM8JK8eu8RpJ4re5Bwm=
FRw6Tr0XlsWOeqQqZTjzwcPKItQR0hTxd9ZQ7rBLYSOuAKeTefElHQ9EZfLoWbvi8z1TsACjrdO=
lflPThE-2FfjKrO2oE5hgz3F99bFs6ymkJAL5hjKbtWLrkB-2BYzNX0AOedNP42fCwgKj2KeSrj=
-2FfHChuHRcYFO2ggA95Hs-2Bogz6Q3lXPwfpj8tAyOz-2BGhICPgSzklv9j3KI3mHxR9vUtX4r=
1APuOFkJ5ygJ2x-2FFzHBe21ccAE0UrohqSWt7VzcSolWHIBzO-2F4TpxaLO3jM5VBhWpwp60RC=
3QVzQ-2FYsSUH3n6DXEDn-2B9RaFXl1Yndd3sIqXwlBBw-3D

** Transparency notifications BlackRock, Inc.
------------------------------------------------------------

=C2=B7 Notifications referring to situation on 31 July, 1, 2 and 5 August 2=
019
=C2=B7 Threshold crossed: 5%
=C2=B7 Latest holding: 5.16%

Brussels (Belgium), 7 August 2019 =E2=80=93 20:00 (CEST) =E2=80=93 regulate=
d information

1.=C2=A0 Summary of the notifications

Pursuant to Article 14 of the law of 2 May 2007 on the disclosure of large =
shareholdings, UCB=C2=A0SA/NV announces that it has received 4 transparency=
notifications from BlackRock, Inc. (having its registered office at 55 Eas=
t 52nd Street, New York, NY, 10055, U.S.A.), dated 1, 2, 5 and 6 August 201=
9 respectively.

In the first notification, BlackRock, Inc., has notified that, following an=
acquisition of UCB=C2=A0shares with voting rights and a disposal of equiva=
lent financial instruments by its affiliates, its total holding in UCB SA/N=
V has increased and has crossed the 5% threshold on 31 July 2019.

On 31 July 2019, BlackRock, Inc. (taking into account the holding of its af=
filiates) Inc. owned 9 581 467 UCB=C2=A0shares with voting rights (versus 9=
438 644 in its previous notification), representing 4.93% of the total num=
ber of shares issued by the company (194 505 658) (versus 4.85% in its prev=
ious notification), as well as 177 514 equivalent financial instruments (ve=
rsus 186 998 in its previous notification) representing 0.09% of the total =
number of shares issued by the company (versus 0,10% in its previous notifi=
cation).

In the second notification, BlackRock, Inc., has notified that, following a=
n acquisition of UCB=C2=A0shares with voting rights by its affiliates, its =
holding of UCB shares with voting rights has increased and has crossed the =
5% threshold on 1 August 2019.

On 1 August 2019, BlackRock, Inc. (taking into account the holding of its a=
ffiliates) owned 9 790 040 UCB=C2=A0shares with voting rights, representing=
5.03% of the total number of shares issued by the company, as well as 184 =
303 equivalent financial instruments, representing 0.09% of the total numbe=
r of shares issued by the company.

In the third notification, BlackRock, Inc., has notified that, following a =
disposal of UCB=C2=A0shares with voting rights by its affiliates, its holdi=
ng of UCB shares with voting rights has decreased and has crossed downwards=
the 5% threshold on 2 August 2019.

On 2 August 2019, BlackRock, Inc. (taking into account the holding of its a=
ffiliates) owned 9 698 910 UCB=C2=A0shares with voting rights, representing=
4.99% of the total number of shares issued by the company, as well as 190 =
730 equivalent financial instruments, representing 0.10% of the total numbe=
r of shares issued by the company.

In the fourth notification, BlackRock, Inc., has notified that, following a=
n acquisition of UCB=C2=A0shares with voting rights by its affiliates, its =
holding of UCB shares with voting rights has increased and has crossed the =
5% threshold on 5 August 2019.

On 5 August 2019, BlackRock, Inc. (taking into account the holding of its a=
ffiliates) owned 9 830 066 UCB=C2=A0shares with voting rights, representing=
5.05% of the total number of shares issued by the company, as well as 199 =
838 equivalent financial instruments, representing 0.10% of the total numbe=
r of shares issued by the company.

2.=C2=A0 Further information

This press release and the detailed transparency notifications are availabl=
e on UCB=C2=A0SA/NV=E2=80=99s website via the following link (https://u7061=
146.ct.sendgrid.net/wf/click?upn=3DG62jSYfZdO-2F12d8lSllQB7X3kY45D7w88RKNKE=
bAnX0k168L1blu4vXqw-2F8RdooEQ6SU3zroSdeAFOVg4KQLSg-3D-3D_-2B-2Ft0TnE1oEbVIW=
S8vHM8JK8eu8RpJ4re5BwmFRw6Tr0XlsWOeqQqZTjzwcPKItQR0hTxd9ZQ7rBLYSOuAKeTefElH=
Q9EZfLoWbvi8z1TsACjrdOlflPThE-2FfjKrO2oE5hgz3F99bFs6ymkJAL5hjKbtWLrkB-2BYzN=
X0AOedNP42fCwgKj2KeSrj-2FfHChuHRcYFO2ggA95Hs-2Bogz6Q3lXPwW-2Fzeev82pUZidshC=
0BR5cIKUnkx7MB78Sp8LqRVm5NBaMe6XlK6MLAFpzNohAIiB3HSID9lg6tBSjK5HkTVh4bX5O5s=
z0AUuCUCvV3aCMx8TH0ymUYwDn9KULLPPRRne20uZePpUrZBlGegTVYRDWk-3D .
An updated overview of the UCB=C2=A0SA/NV large shareholdings will be avail=
able on UCB=C2=A0SA/NV=E2=80=99s website via the following link (https://u7=
061146.ct.sendgrid.net/wf/click?upn=3DG62jSYfZdO-2F12d8lSllQB7X3kY45D7w88RK=
NKEbAnX0k168L1blu4vXqw-2F8RdooEQ6SU3zroSdeAFOVg4KQLSg-3D-3D_-2B-2Ft0TnE1oEb=
VIWS8vHM8JK8eu8RpJ4re5BwmFRw6Tr0XlsWOeqQqZTjzwcPKItQR0hTxd9ZQ7rBLYSOuAKeTef=
ElHQ9EZfLoWbvi8z1TsACjrdOlflPThE-2FfjKrO2oE5hgz3F99bFs6ymkJAL5hjKbtWLrkB-2B=
YzNX0AOedNP42fCwgKj2KeSrj-2FfHChuHRcYFO2ggA95Hs-2Bogz6Q3lXPweYuc-2BiB5O-2Bs=
wqFTBs-2FUDKV9cISSI1P3uybQb74ewZbfoOYBNnfxvKoCgiQAasRb9WXNyND5gSYvtScHA-2BL=
X2tf6rJW7FcY-2FPqCfu7mHc7a-2B-2BUpMhAziCidQmWhOTwc0SMf0wWahsudfv3D3AHCr-2Bo=
E-3D .

Investor Relations

Antje Witte,
Investor Relations, UCB
T +32 2 559 94 14,
antje.witte@ucb.com

Isabelle Ghellynck,
Investor Relations, UCB
T +32 2 559 95 88,
isabelle.ghellynck@ucb.com

About UCB
UCB, Brussels, Belgium (www.ucb.com (https://u7061146.ct.sendgrid.net/wf/cl=
ick?upn=3D84Em28S1K9SvtzcUtu04EmJ6qK6m5fEduQTondOjhxU-3D_-2B-2Ft0TnE1oEbVIW=
S8vHM8JK8eu8RpJ4re5BwmFRw6Tr0XlsWOeqQqZTjzwcPKItQR0hTxd9ZQ7rBLYSOuAKeTefElH=
Q9EZfLoWbvi8z1TsACjrdOlflPThE-2FfjKrO2oE5hgz3F99bFs6ymkJAL5hjKbtWLrkB-2BYzN=
X0AOedNP42fCwgKj2KeSrj-2FfHChuHRcYFO2ggA95Hs-2Bogz6Q3lXPwYSoerCVVu9-2Fh7ocG=
C9ImCAOhCfmnKI21eJxaym9nvGbxlSv6qdNqENKhnhyT02lUGrn03YT7zt1ywlToVoZJrSwOjib=
f-2B2sDBFZQJ9fig4SBJnCsn5bthDNG7WaaO5huSzGSice2qx8SeSdQIHkE-2Bo-3D ) is a g=
lobal biopharmaceutical company focused on the discovery and development of=
innovative medicines and solutions to transform the lives of people living=
with severe diseases of the immune system or of the central nervous system=
. With 7 500 people in approximately 40 countries, the company generated re=
venue of =E2=82=AC 4.6 billion in 2018. UCB is listed on Euronext Brussels =
(symbol: UCB). Follow us on Twitter: @UCB_news

GenericFile
190807 - Notification de transparence comm de presse Blackrock (https://u70=
61146.ct.sendgrid.net/wf/click?upn=3DG62jSYfZdO-2F12d8lSllQBx1W27HkUdGSImvH=
Q6HnxeeiysVZrCZyCvoCjypIVyRo7x24r9zgmfNi7f8eBc1Y-2F3Jo1atWJXbaCsfBOk75ioc-3=
D_-2B-2Ft0TnE1oEbVIWS8vHM8JK8eu8RpJ4re5BwmFRw6Tr0XlsWOeqQqZTjzwcPKItQR0hTxd=
9ZQ7rBLYSOuAKeTefElHQ9EZfLoWbvi8z1TsACjrdOlflPThE-2FfjKrO2oE5hgz3F99bFs6ymk=
JAL5hjKbtWLrkB-2BYzNX0AOedNP42fCwgKj2KeSrj-2FfHChuHRcYFO2ggA95Hs-2Bogz6Q3lX=
PwYlGrn74CA2ni6E40oXSs2tAVkfzKRIE2VrfCmf35niHmkXUbsY20yjWY3GK-2B-2FdcdoMeq0=
uW0SBlUo8rPkiBl7mtNM1FkADngeI9HdX9NA2MsVLRnPB6-2FGmRUEwaBep2fS-2F-2FbVn7cpo=
rpsymQuyN7Iw-3D GenericFile
190807- Transparantieverklaring persbericht BlackRock (https://u7061146.ct.=
sendgrid.net/wf/click?upn=3DG62jSYfZdO-2F12d8lSllQBx1W27HkUdGSImvHQ6Hnxeeiy=
sVZrCZyCvoCjypIVyRosD7tnlT-2Bfu1W2746wbbz-2BExAM0bvq-2FBMqbi61zQyrFg-3D_-2B=
-2Ft0TnE1oEbVIWS8vHM8JK8eu8RpJ4re5BwmFRw6Tr0XlsWOeqQqZTjzwcPKItQR0hTxd9ZQ7r=
BLYSOuAKeTefElHQ9EZfLoWbvi8z1TsACjrdOlflPThE-2FfjKrO2oE5hgz3F99bFs6ymkJAL5h=
jKbtWLrkB-2BYzNX0AOedNP42fCwgKj2KeSrj-2FfHChuHRcYFO2ggA95Hs-2Bogz6Q3lXPwfD6=
THajQAVQ60WMN5SCFBwMNJkzwRgBAdOCBuY-2FEUEiAxkVx-2BRSY4T5XWwnyfIAxMmUaDVMBU5=
C1-2BT5GNbue8iC-2FuSmpKUdQlraLvkIl9m33ZDN0EtCfCwysOfLyKnCk-2BDdNtj4t3iGvOz7=
NKUJ1RQ-3D=0D
=0D
______________________=0D
If you would rather not receive future communications from UCB SA, please g=
o to https://u7061146.ct.sendgrid.net/wf/click?upn=3DG62jSYfZdO-2F12d8lSllQ=
Bz2p53T0v-2BoEIvbo6vDi8C-2BOyFzyb6obo-2BzKSgNKq4mrcihVlfgSqlqm97zB-2FvNch5-=
2BSbmgMo4yrX46hjnekCN6PvikuZxo2OdNn-2FR6wxU4TvSx7IIHzJzJJH3DtoqnU-2FDS4rn3j=
s2o8DYZpfyMJZUc-3D_-2B-2Ft0TnE1oEbVIWS8vHM8JK8eu8RpJ4re5BwmFRw6Tr0XlsWOeqQq=
ZTjzwcPKItQR0hTxd9ZQ7rBLYSOuAKeTefElHQ9EZfLoWbvi8z1TsACjrdOlflPThE-2FfjKrO2=
oE5hgz3F99bFs6ymkJAL5hjKbtWLrkB-2BYzNX0AOedNP42fCwgKj2KeSrj-2FfHChuHRcYFO2g=
gA95Hs-2Bogz6Q3lXPwU3Cq61aUPbbVolFkONxN-2BBQ3R6cKmFvDbEDvnXVSGZ3Ty7az-2FXcR=
x3qYZdoOws4HufNKnqWuflrOeYrkXw3QMhmK4QjFCrKvD6EIIaYT-2BPzfL7asOxUFPViBLhn3d=
bmk-2FIQ-2F-2BFuz9Tp3vPtmvQgdyc-3D=0D
UCB SA, All=C3=A9e de la Recherche, 60 ., Brussels, . B - 1070 Belgium=